General Principles of Preclinical Study Design

Wenlong Huang*, Nathalie Percie du Sert, Jan Vollert, Andrew S C Rice

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Preclinical studies using animals to study the potential of a therapeutic drug or strategy are important steps before translation to clinical trials. However, evidence has shown that poor quality in the design and conduct of these studies has not only impeded clinical translation but also led to significant waste of valuable research resources. It is clear that experimental biases are related to the poor quality seen with preclinical studies. In this chapter, we will focus on hypothesis testing type of preclinical studies and explain general concepts and principles in relation to the design of in vivo experiments, provide definitions of experimental biases and how to avoid them, and discuss major sources contributing to experimental biases and how to mitigate these sources. We will also explore the differences between confirmatory and exploratory studies, and discuss available guidelines on preclinical studies and how to use them. This chapter, together with relevant information in other chapters in the handbook, provides a powerful tool to enhance scientific rigour for preclinical studies without restricting creativity.
Original languageEnglish
Title of host publicationHandbook of Experimental Pharmacology
Place of PublicationBerlin
PublisherSpringer
Pages1-15
Number of pages15
DOIs
Publication statusE-pub ahead of print - 10 Nov 2019

Fingerprint

Creativity
Clinical Trials
Guidelines
Research
Pharmaceutical Preparations
Therapeutics

Keywords

  • experimental bias
  • hypothesis generating
  • hypothesis testing
  • in vivo studies
  • preclinical research

Cite this

Huang, W., du Sert, N. P., Vollert, J., & Rice, A. S. C. (2019). General Principles of Preclinical Study Design. In Handbook of Experimental Pharmacology (pp. 1-15). Berlin: Springer . https://doi.org/10.1007/164_2019_277

General Principles of Preclinical Study Design. / Huang, Wenlong; du Sert, Nathalie Percie; Vollert, Jan ; Rice, Andrew S C.

Handbook of Experimental Pharmacology. Berlin : Springer , 2019. p. 1-15.

Research output: Chapter in Book/Report/Conference proceedingChapter

Huang, W, du Sert, NP, Vollert, J & Rice, ASC 2019, General Principles of Preclinical Study Design. in Handbook of Experimental Pharmacology. Springer , Berlin, pp. 1-15. https://doi.org/10.1007/164_2019_277
Huang W, du Sert NP, Vollert J, Rice ASC. General Principles of Preclinical Study Design. In Handbook of Experimental Pharmacology. Berlin: Springer . 2019. p. 1-15 https://doi.org/10.1007/164_2019_277
Huang, Wenlong ; du Sert, Nathalie Percie ; Vollert, Jan ; Rice, Andrew S C. / General Principles of Preclinical Study Design. Handbook of Experimental Pharmacology. Berlin : Springer , 2019. pp. 1-15
@inbook{5e4bae61676046f78854992005ee59b9,
title = "General Principles of Preclinical Study Design",
abstract = "Preclinical studies using animals to study the potential of a therapeutic drug or strategy are important steps before translation to clinical trials. However, evidence has shown that poor quality in the design and conduct of these studies has not only impeded clinical translation but also led to significant waste of valuable research resources. It is clear that experimental biases are related to the poor quality seen with preclinical studies. In this chapter, we will focus on hypothesis testing type of preclinical studies and explain general concepts and principles in relation to the design of in vivo experiments, provide definitions of experimental biases and how to avoid them, and discuss major sources contributing to experimental biases and how to mitigate these sources. We will also explore the differences between confirmatory and exploratory studies, and discuss available guidelines on preclinical studies and how to use them. This chapter, together with relevant information in other chapters in the handbook, provides a powerful tool to enhance scientific rigour for preclinical studies without restricting creativity.",
keywords = "experimental bias, hypothesis generating, hypothesis testing, in vivo studies, preclinical research",
author = "Wenlong Huang and {du Sert}, {Nathalie Percie} and Jan Vollert and Rice, {Andrew S C}",
year = "2019",
month = "11",
day = "10",
doi = "10.1007/164_2019_277",
language = "English",
pages = "1--15",
booktitle = "Handbook of Experimental Pharmacology",
publisher = "Springer",

}

TY - CHAP

T1 - General Principles of Preclinical Study Design

AU - Huang, Wenlong

AU - du Sert, Nathalie Percie

AU - Vollert, Jan

AU - Rice, Andrew S C

PY - 2019/11/10

Y1 - 2019/11/10

N2 - Preclinical studies using animals to study the potential of a therapeutic drug or strategy are important steps before translation to clinical trials. However, evidence has shown that poor quality in the design and conduct of these studies has not only impeded clinical translation but also led to significant waste of valuable research resources. It is clear that experimental biases are related to the poor quality seen with preclinical studies. In this chapter, we will focus on hypothesis testing type of preclinical studies and explain general concepts and principles in relation to the design of in vivo experiments, provide definitions of experimental biases and how to avoid them, and discuss major sources contributing to experimental biases and how to mitigate these sources. We will also explore the differences between confirmatory and exploratory studies, and discuss available guidelines on preclinical studies and how to use them. This chapter, together with relevant information in other chapters in the handbook, provides a powerful tool to enhance scientific rigour for preclinical studies without restricting creativity.

AB - Preclinical studies using animals to study the potential of a therapeutic drug or strategy are important steps before translation to clinical trials. However, evidence has shown that poor quality in the design and conduct of these studies has not only impeded clinical translation but also led to significant waste of valuable research resources. It is clear that experimental biases are related to the poor quality seen with preclinical studies. In this chapter, we will focus on hypothesis testing type of preclinical studies and explain general concepts and principles in relation to the design of in vivo experiments, provide definitions of experimental biases and how to avoid them, and discuss major sources contributing to experimental biases and how to mitigate these sources. We will also explore the differences between confirmatory and exploratory studies, and discuss available guidelines on preclinical studies and how to use them. This chapter, together with relevant information in other chapters in the handbook, provides a powerful tool to enhance scientific rigour for preclinical studies without restricting creativity.

KW - experimental bias

KW - hypothesis generating

KW - hypothesis testing

KW - in vivo studies

KW - preclinical research

U2 - 10.1007/164_2019_277

DO - 10.1007/164_2019_277

M3 - Chapter

SP - 1

EP - 15

BT - Handbook of Experimental Pharmacology

PB - Springer

CY - Berlin

ER -